Modern corporate building against direct sun.
Our Work

Latham & Watkins Represents Marex Group plc in US$292 Million IPO

April 25, 2024
Cross-border, multidisciplinary team advises the UK-headquartered diversified global financial services platform on the offering.

Marex Group plc, the UK-headquartered diversified global financial services platform, has announced the pricing of its initial public offering, at US$19 per share. A total of 15,384,615 ordinary shares are being offered, of which 3,846,153 shares are being offered by Marex and 11,538,462 shares are being offered by certain selling shareholders. Marex will not receive any proceeds from any sale of shares by the Selling Shareholders. The ordinary shares began trading on the Nasdaq Global Select Market on April 25, 2024, under the ticker symbol “MRX.” The offering is expected to close on April 29, 2024, subject to customary closing conditions.

Latham & Watkins LLP represents Marex in the offering with a capital markets team led by New York partners Marc Jaffe and Ian Schuman and London partner Jennifer Gascoyne, with associates Sarah Youssefi, Summer Xia, and Alex Harvey. Advice was also provided on US benefits and compensation matters by New York partner Bradd Williamson, with associate Alisa Hand; on UK benefits and compensation matters by London partners Kendall Burnett with associate Joshua Atkinson; on US ESG matters by New York partner Betty Huber, with associate Karmpreet Grewal; on UK ESG and financial regulatory matters by London partner Nicola Higgs and London counsel Anne Mainwaring, with associates Jonathan Ritson-Candler, Sara Sayma, and Jaime Martin; on US financial regulatory matters by New York partner Stephen Wink and counsel Naim Culhaci; on CFTC matters by New York partner Yvette Valdez, with associate Naffie Lamin; on public company representation matters by New York counsel Emily Corbi, with associate Shahar Gonen; on UK tax matters by London partner Sean Finn, with associate Joshua Atkinson; and on US tax matters by New York partners Jiyeon Lee-Lim and Elena Romanova, with associate Farrah Yan.

Endnotes